Central Admixture Pharmacy Services, Inc. is recalling specific lots of Phenylephrine added to 0.9% sodium chloride IV bags because they contain visible particulate matter. This Class I recall affects 1,546 bags distributed nationwide within the United States. The presence of foreign particles in an intravenous medication poses a significant health risk if injected into a patient. Read more at govinfonow.com/recall/32269-recall-phenylephrine-iv-bags-with-particulate-matter.
“Recall: Phenylephrine IV Bags with Particulate Matter.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32269-recall-phenylephrine-iv-bags-with-particulate-matter. Based on FDA recall #D-0272-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0272-2025%22&limit=1).
The FDA announced on Feb. 20, 2025, that Central Admixture Pharmacy Services is recalling Phenylephrine IV bags due to the presence of particulate matter. The Class I recall affects 1,546 bags distributed nationwide.
The recall is due to the presence of particulate matter in the Phenylephrine IV bags. The FDA classified this as a Class I recall, indicating a high risk of adverse health consequences.
Context
GovInfoNow's records show Central Admixture Pharmacy Services has issued nine other recalls since May 28, 2014. Recent brand recalls include pediatric TPN bags with incorrect formulations on July 16, 2026, and June 2, 2026, as well as a Fentanyl bag recall due to sterility risks on Sept. 21, 2023. Other recent recalls of similar products include an American Regent Multrys IV injection recall for particulate matter contamination risk (July 24, 2026), an Epinephrine Injection recall for particulate matter risk (Aug. 11, 2026), and a Papaverine HCl Injection recall for particulate matter hazard (July 24, 2026).
How to tell if you have this one
Check for bags labeled 'PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL (160 mcg/mL), Rx Only'. Verify the lot numbers: 37-928390 (Exp 03MAR2025), 37-928796 (Exp 09MAR2025), or 37-928839 (Exp 10MAR2025). The NDC is 71285-6092-1.
Brand
Central Admixture Pharmacy Services
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using the Product
Do not administer these IV bags to any patient due to the risk of particulate matter exposure.
Identify Affected Lots
Verify if your inventory contains lots 37-928390, 37-928796, or 37-928839 with expiration dates in March 2025.
Contact Manufacturer
Call Central Admixture Pharmacy Services at 855-275-2270 for further instructions on the remedy or return process.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Product was distributed nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 27 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0272-2025 (February 20, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0272-2025 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.